Alsieni M, Babader R, Kenany S, Abdulgader S, Alafif R, Alahmadi A, Aloufi A, Fallatah E, AlQahtani R, Izaldin A. The prevalence Regarding the Use of Glucagon-like Peptide-1 (GLP-1) Agonists as an Obesity Treatment among Adult Patients at King Abdulaziz University Medical Services Center, Jeddah, Saudi Arabia: a Descriptive Cross-Sectional Study: The prevalence of Glucagon-like Peptide-1 (GLP-1) Agonists use as an Obesity Treatment among adults in Saudi Arabia. JKAU Med Sci [Internet]. 2024 Dec. 1 [cited 2025 Jan. 22];31(2). Available from: https://journals.kau.edu.sa/index.php/MedSci/article/view/2412